Free Trial

Belite Bio (BLTE) Institutional Ownership

Belite Bio logo
$56.91 -0.34 (-0.59%)
As of 02/21/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Belite Bio (NASDAQ:BLTE)

Current
Institutional Ownership
Percentage
0.53%
Number of
Institutional Buyers
(last 12 months)
8
Total
Institutional Inflows
(last 12 months)
$8.70M
Number of
Institutional Sellers
(last 12 months)
4
Total
Institutional Outflows
(last 12 months)
$470.86K
Get BLTE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Belite Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

BLTE Institutional Buying and Selling by Quarter

Belite Bio Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2025 Citadel Advisors LLC5,211$329K0.0%-19.3%0.017%
2/17/2025 Bank of America Corp DE18,342$1.16M0.0%+36.4%0.059%
2/17/2025 BNP Paribas Financial Markets2,450$155K0.0%N/A0.008%
2/14/2025 Virtus ETF Advisers LLC1,122$71K0.0%-39.1%0.004%
2/13/2025 Marshall Wace LLP5,865$370K0.0%-30.9%0.018%
2/13/2025 XTX Topco Ltd7,062$446K0.0%+30.9%0.022%
2/12/2025 JPMorgan Chase & Co.14,636$924K0.0%+130.3%0.047%
1/28/2025 Advisors Preferred LLC798$52K0.0%N/A0.003%
1/3/2025 GAMMA Investing LLC1,290$81K0.0%+48.1%0.004%
12/26/2024 JPMorgan Chase & Co.6,356$298K0.0%+7,122.7%0.021%
11/15/2024 XTX Topco Ltd5,394$253K0.0%N/A0.018%
11/15/2024 State Street Corp20,086$942K0.0%+28.2%0.066%
11/15/2024 Point72 Asset Management L.P.4,800$225K0.0%-34.3%0.016%
10/7/2024 GAMMA Investing LLC871$41K0.0%+103.5%0.003%
8/19/2024 Point72 Asset Management L.P.7,311$334K0.0%-16.0%0.025%
8/15/2024 Armistice Capital LLC148,000$6.76M0.1%N/A0.497%
2/13/2024 Armistice Capital LLC36,000$1.65M0.0%N/A0.130%
2/7/2024 Jump Financial LLC5,200$238K0.0%N/A0.019%
11/8/2023 Atria Wealth Solutions Inc.74,019$2.36M0.0%-90.9%0.272%
8/3/2023 Atria Wealth Solutions Inc.814,498$11.64M0.2%+0.3%3.268%
2/13/2023 Atria Wealth Solutions Inc.811,765$24.47M0.4%+1,397.6%3.264%
11/3/2022 Barclays PLC6,661$223K0.0%N/A0.027%
8/15/2022 Atria Wealth Solutions Inc.49,463$1.54M0.0%N/A0.199%
(Data available from 1/1/2016 forward)

BLTE Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of BLTE shares?

During the previous two years, 14 institutional investors and hedge funds held shares of Belite Bio. The most heavily invested institutionals were Armistice Capital LLC ($6.76M), Atria Wealth Solutions Inc. ($2.36M), Bank of America Corp DE ($1.16M), State Street Corp ($942K), JPMorgan Chase & Co. ($924K), XTX Topco Ltd ($446K), and Marshall Wace LLP ($370K).Learn more on BLTE's institutional investors.

What percentage of Belite Bio stock is owned by institutional investors?

0.53% of Belite Bio stock is owned by institutional investors. Learn more on BLTE's institutional investor holdings.

Which institutional investors have been buying Belite Bio stock?

Of the 10 institutional investors that purchased Belite Bio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($184K), JPMorgan Chase & Co. ($14.55K), XTX Topco Ltd ($7.06K), Jump Financial LLC ($5.20K), Bank of America Corp DE ($4.89K), State Street Corp ($4.42K), and Atria Wealth Solutions Inc. ($2.73K).

How much institutional buying is happening at Belite Bio?

Institutional investors have bought a total of 226,959 shares in the last 24 months. This purchase volume represents approximately $10.63M in transactions.

Which Belite Bio major shareholders have been selling company stock?

The following institutional investors have sold Belite Bio stock in the last 24 months: Atria Wealth Solutions Inc. ($740.48K), Point72 Asset Management L.P. ($3.90K), Marshall Wace LLP ($2.62K), Citadel Advisors LLC ($1.25K), and Virtus ETF Advisers LLC ($721.00).

How much institutional selling is happening at Belite Bio?

Institutional investors have sold a total of 748,970 shares in the last 24 months. This volume of shares sold represents approximately $24.06M in transactions.



This page (NASDAQ:BLTE) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners